Mupirocin EP Imp. I is a thiazole-containing impurity arising from the synthetic pathway of mupirocin, characterized by a hydroxymethyl substituent at the 2-position of the thiazole moiety and a truncated side chain lacking the methylthiomethyl group present in the parent compound. This structural deviation results from an incomplete alkylation step during mupirocin synthesis. The compound functions as a critical HPLC reference standard for quantifying process-related impurities in mupirocin active pharmaceutical ingredients.
On Request